Work

Efficient dual treatment of the hormone-refractory prostate cancer cell line DU145 with cetuximab and 1,25-dihydroxyvitamin D3.

Year: 2007

Type: article

Source: PubMed

Authors: Olga Belochitski, Samuel Ariad, Shraga Shany, Vladimir Fridman, Vladimir Gavrilov

Institutions: Ben-Gurion University of the Negev, Soroka Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2186728337

FWCI: 0.347

Cites: 28

Cited by: 13

Related to: 10